Acute and chronic liver injury is often complicated by cholestatic episodes, which trigger metabolic or infectious complications independent of the underlying aetiology. This can ultimately result in severe disturbance of body homeostasis, disease progression or potentially lethal septic complications. 1 Therefore, a better understanding of relevant organ-protecting mechanisms is helpful to improve the prognosis of the patients.
The innate hepatic antimicrobial host defence involves several mechanisms. First, microbial pathogens are recognized (bacterial recognition) via its surface molecules, eg, lipopolysaccharide (LPS; Gram-negative bacteria) through LPS-binding protein (LBP) 2 and its co-receptor CD14 3 both forming a complex with Toll-like receptor 4 (TLR4). TLR4 activates a signalling cascade, involving TIRAP, 4 MyD88 5 and among others IRAK1/4 kinases 6 , which triggers activation of the innate hepatic immune response. This includes an increase in the expression of proinflammatory genes involved in recruiting white blood cells to the site of inflammation. Beside TLRs also intracellular pattern recognition factors, eg, NOD1 and NOD2, 7 are important for the recognition of microbial elements and the initiation of the innate immune response. 8 In turn the formation of the inflammasome is triggered by a wide range of pathogen-and host-derived 'danger' signals. Additional protective mechanisms are provided through the secretion of antimicrobial peptides (AMPs), such as cathelicidins by neutrophils 9 and the activation of the acute-phase response (APR) is through interleukin (IL)-6/gp130-dependent signals. 10 Essential factors for maintaining liver cell integrity and controlling liver regeneration are cytokines (IL-6, TNF-a and TGF-b) and growth factors (HGF, EGF and KGF). Here, we focused on the HGF receptor tyrosine kinase c-Met and the IL-6 signalling transducer gp130, which have important roles in the maintenance of liver organ homeostasis.
Gp130 is the key receptor regulating the APR and is essential for the induction of the SAA gene family via signalling transducer and activator of transcription-3 (STAT3), 11 which helps to defeat bacterial infections in mice. 12 Further analysis demonstrated gp130 as an important modulator of cell cycle induction after liver injury. 13 C-Met is one of the most important factors for the initiation of cellular proliferation in quiescent hepatocytes and during liver regeneration 14 and in preventing liver fibrogenesis. 15 As both receptor systems were shown to mediate regenerative, anti-fibrotic and immunoprotective functions, we hypothesised that they may act synergistically hepatoprotective. Potential cooperative mechanisms initiated by either pathway with special focus on antimicrobial defence mechanisms were therefore investigated in a model of experimentally induced cholestasis.
MATERIALS AND METHODS Generation of Hepatocyte-Specific c-Met and gp130 Knockout Mice
The generation of functional hepatocyte-specific c-Met (c-Met Dhepa ) 16 and gp130 (gp130 Dhepa ) knockout mice was described before. 17 
Viable c-Met
Dhepa offspring carrying a postnatal active albumin-Cre promoter construct were crossbreaded with gp130 loxP/loxP mice to obtain c-Met/gp130 double conditional knockout mice. C-Met/gp130 offspring were then born with a normal Mendelian frequency. Cre and loxP status were analysed by PCR using a Ready-Taq system (Sigma-Aldrich, Steinheim, Germany).
Bile Duct Ligation (BDL)
Eight-to ten-week-old C57/B6 mice (Cre( À ) and Cre( þ ) c-Met loxp/loxP mice) were subjected to BDL for up to 4 weeks. BDL was performed by tying the common bile duct using a non absorbable filament (Ethicon, Boston, MA, USA). For each of the following analysis at least four mice per time point were investigated. All experiments were performed at least twice.
Evaluation of Statistical Significance
All significant P-values were calculated and proven via Student's t-test.
Immunoblotting
For the detection of phosphorylated STAT3 liver nuclear extracts were prepared. Cytoplasmic protein of 50 mg was loaded on a 10% SDS-PAGE and run for 1.5 h. The proteins were transferred to a PVDF membrane using a wet blotting system (Bio-Rad, Munich, Germany). Next, the membrane was blocked in TBS-T containing 5% dry milk powder. The anti-phospho STAT3, anti-phospho p65, anti phospho c-Jun N-terminal kinase (JNK)1/2, JNK1/2, anti-phospho p38, p38 antibody, anti-ERK1/2, anti IRAK4 (Cell Signalling/NEB, Frankfurt/Main, Germany), TRAF6 (Santa Cruz, Heidelberg, Germany), MyD88 (eBioscience, Frankfurt/Main, Germany) and GAPDH (Abd Serotec, Duesseldorf, Germany) were incubated over night at 4 1C according to the manufacturer's instructions. For detection and visualization (LAS-3000 System, FujiFilm, Germany) a secondary horseradish peroxidase-conjugated antibody (Cell Signalling or Santa Cruz) and ECL solution (Pierce, Bonn, Germany) were used.
Immunofluorescent Stainings
Cryopreserved liver tissue was cut in 5-mm sections. Neutrophils were stained using a rat anti-mouse Ly6G antibody (BD Bioscience, Heidelberg, Germany). The antibody was incubated for 1 h at room temperature in 1% mouse serum dissolved in PBS (PAA, Vienna, Austria) containing 0.02% sodium acetate (Sigma-Aldrich). Cathelin-related antimicrobial peptide (CRAMP) was detected using an anti-CRAMP antibody (Santa Cruz) and an Alexa 594 secondary antibody (Molecular Probes/Invitrogen, Karlsruhe, Germany). Detection of Ly6G was performed using an Alexa 488 secondary antibody (Molecular Probes/Invitrogen). Ki67 antibody was purchased from (Dako, Hamburg, Germany) and counterstained using an Alexa 488-conjungated secondary antibody.
DNA strand breaks were detected using the TUNEL detection Kit (Roche, Mannheim, Germany). Nuclei were counterstained with DAPI (Vector Laboratories/Axxora, Loerrach). Immunofluorescent signals were detected using an AxioImager Z1 microscope (Carl Zeiss, Jena, Germany). Images were taken in a Â 200 magnification.
Histology
Liver samples were fixed in 3.5% formaldehyde, embedded in paraffin and cut 2-3 mm strong. The sections were incubated for 5 min in haematoxylin according to Mayer (Roth, Karlsruhe, Germany). After washing with hand warm water, eosin (Roth) treatment was followed for 1 min, slides were rinsed and dehydrated in an increasing ethanol row and finished in Roti-Histol (Roth). Slides were mounted by using RotiHistokit (Roth). Pictures were taken ( Â 100 magnification) using the brightfield option of the Axio-Imager Z1 (Carl Zeiss).
For assignation of necrotic areas sections were counted. A minimum of five view fields per tissue/mouse was counted for each time point per genotype.
Gene Expression Analysis by Real-Time PCR Total RNA was extracted from cryopreserved liver tissue by using peqGold RNAPuret (PeqLab, Erlangen, Germany). After isolation 500 ng of total RNA were transcribed into cDNA by using the RT Omniscript Kit (Qiagen, Hilden, Germany). The detection of cDNA expression for specific genes was performed by using the Sybr s GreenERt qPCR 
LPS Stimulation In Vivo and In Vitro
To investigate the LPS response in vivo mice received an intraperitoneal injection of 10 mg LPS (Sigma Aldrich) dissolved in PBS (pH 7.4; PAA, Cologne, Germany). After 6 h, the mice were killed, blood samples were taken; the liver was resected and cryopreserved for further analysis. After overnight incubation, primary hepatocytes were stimulated with 10 mg LPS for 6 h. To isolate RNA for gene expression analysis cells were lysed using RLT buffer from the RNeasy Mini Kit (Qiagen). Untreated cells were used as controls.
RESULTS

Enhanced Mortality of Mice Lacking Hepatic gp130
Activation During the Early Phase After BDL Transgenic mouse strains carrying hepatocyte-specific deletions of c-Met (c-Met
Dhepa ) and their respective controls (c-Met/ gp130
DloxP/loxP ) were subjected to BDL. Interestingly, c-Met/ gp130
Dhepa and gp130 Dhepa mice showed enhanced mortality rates already 2 (c-Met/gp130
Dhepa ) and 4 (gp130
Dhepa
) days after BDL whereas c-Met
Dhepa and control mice survived the critical early phase after BDL ( Figure 1a ). Overall survival 7 days after BDL was 37.5% in gp130
Dhepa , 50% in c-Met/ gp130
Dhepa vs 100% in controls and c-Met-deleted mice. During a longer observation period (up to 4 weeks) control mice survived indefinitely, c-Met Dhepa displayed 87.5% survival, while in both groups with gp130 deletion only 20% long-term survivors were evident.
Histological liver analysis unravelled more necrotic areas and tissue injury in mice with a hepatocyte-specific deletion of c-Met, gp130 or both in comparison with control mice (Figures 1b and c) . The largest number of necrotic areas was observed in livers of c-Met/gp130
Dhepa mice (11±3 as compared with 2.4 in controls, Po0.001), which might be due to their inability to compensate the onset of cholestatic liver injury. Transaminases were increased in either genotype with no significant differences among subgroups (data not displayed). . This is supported by prior findings showing a higher sensitivity of c-Met-deficient hepatocytes during liver injury. 15 Compensatory cell proliferation in bile duct- ). This underlines that also the proliferation of biliary epithelial cells was correlated to the higher degree of liver injury in conditional knockout mice, interestingly being strongest in double-knockout mice.
Inflammation and Apoptosis Rates Correlate with Cholestatic Liver Injury
Bile Duct-Ligated Mice Show an Enhanced Bacterial Load BDL is known to trigger translocation of intestinal bacteria into the blood. 1,17 Therefore, we tested the hypothesis whether differences in the bacterial load might explain the observed phenotype between the groups after BDL. Bacterial colony-forming unit (CFU) assays were performed from blood and homogenised liver tissue of bile duct-ligated mice. C-Met/gp130 loxP/loxP showed almost no detectable bacterial translocation (4.25±4 Â 10 3 c.f.u.). In contrast, gp130 ) mice whereas controls showed no significant CFUs (Figures 3a and b) .
c-Met and gp130 Regulate Molecules Involved in the Hepatic Bacterial Recognition After BDL In mammals, the unspecific antibacterial response consists of the classical bacterial recognition leading to the activation of the TLR4 pathway, the induction of AMPs and the activation of the inflammasome network.
The occurrence of an enhanced bacterial infiltration thus directed us to investigate those mechanisms in more detail.
Real-time PCR analysis unravelled a 4.5-fold increased expression of LBP mRNA in livers of c-Met Dhepa mice, whereas c-Met/ gp130 loxP/loxP , gp130
Dhepa and c-Met/gp130 Dhepa mice displayed only a twofold increase (Figure 3c ). Analysis of its co-receptor CD14 showed a significantly lower expression in a c-Metdependent manner. c-Met
Dhepa and c-Met/gp130 Dhepa mice compared with mice with an active c-Met signalling pathway (Figure 3d ). This is in concordance with our previously conducted gene array analysis (Supplementary Table 1) . 15 A next step in the innate immune response defending bacterial infections is the secretion of AMPs by infiltrating 9 Hence, we analysed the expression of CRAMP-one of the best described AMPs-via real-time PCR. The most significant induction was observed in liver tissue of c-Met/gp130 Dhepa mice-the group with the highest bacterial load (Figure 3e ). This expression pattern is further correlated to the number of infiltrating neutrophils (Figure 1d ), which are known as the primary source for CRAMP. By using immunohistochemical double staining we were able to co-localise CRAMP expression on neutrophils (Figure 3f ). Interestingly, we observed a significant induction of CRAMP expression directly in isolated primary hepatocytes (Supplementary Figure 2a) , with absolute levels being much lower than in immune cells. Figure 2d) . Thus, the induction of the Nlrp3 gene correlated with the detectable level of bacterial colonies after BDL.
Hepatocyte-Specific gp130 Deletion Changes the Expression of Genes Involved in the TLR4/MyD88
Pathway As TLR4 is a key component of the innate immune systemwhich gets activated during bacteraemia-we analysed its functionality to ensure the relevance of this pathway. Figure 3f) . To possibly decipher cholestasismediated effects from infection-triggered signalling mechanisms, we challenged mice with LPS. This analysis showed a similar gene expression pattern for members of the antibacterial response (LBP, CD14, TLR4, MyD88 and TIRAP) as seen after BDL (Supplementary Figures 3a-e) .
Hepatic c-Met and gp130 Deficiency Enhances the Inflammatory and Hampers the Anti-Inflammatory Response in Mice
As a response to injury, the liver produces cytokines to recruit immune cells to the origin of inflammation. 18, 19 First, the loxP/loxP control mice (Figure 5d, fourth panel) . Protein expression analysis of the TAK1 adaptor molecule TRAF6-a component of the TLR4 signalling pathway-showed a diminished expression of this factor in mice lacking either hepatic c-Met or gp130 signalling, whereas control mice were able to activate TRAF6 (Figure 5d, sixth panel) .
The Acute Phase Response is Regulated Independently by Both gp130 and c-Met
Finally, we investigated the APR, a major component of the innate immune response that gets activated during liver in- (Figure 6b ). The STAT3-dependent APR gene SAA was regulated concordantly (Figures 6c and d) . HAMP (Hepcidin), which also serves as an APR gene, was analysed by realtime PCR (Figure 6e ) and showed an almost similar expression pattern as found for SAA. This dependency of the SAA and Hepcidin regulation on HGF-mediated signalling could be confirmed by gene array analysis. 15 The finding of reduced APR expression in c-Met Dhepa animals was confirmed on the protein level. Reduced SAA levels were evident in serum (Figure 6d Finally, we analysed the activation of p42/44 MAPK and JNK1/2 after BDL. Phosphorylation of both kinases was impaired if either c-Met or gp130 are lacking as shown by western blot (Figures 6f and g ). To exclude unspecific cholestasis-related effects triggered by BDL-dependent injury, we also challenged control and knockout strains with LPS. Notably, after LPS stimulation c-Met Dhepa mice showed reduced STAT3 phosphorylation and lower expression of SAA (Supplementary Figures 4a and b) .
DISCUSSION
Cholestasis-associated hepatitis and hepatic failure in human are often complicated by increased susceptibility to toxins and therefore associated with infectious complications. A better understanding of cholestasis-related pathogenetic factors is thus important to develop novel strategies to therapeutically target these molecular mechanisms. Previous studies demonstrated that besides inflammatory cytokines (IL-6 13 and TNF-a 20 ) also the growth factor HGF 14, 15, 21 was upregulated during cholestatic liver injury. Moreover, both IL-6/gp130 and HGF/c-Met controlled pathways were independently shown to limit the progression of experimentally induced cholestasis 15, 22 in animal models. Here, we demonstrate that deletion of both gp130 and c-Met signalling in hepatocytes leads to an additive degree of parenchymal and biliary tissue injury (Figures 1b, c and 2c ) and a dysregulation of the hepatic innate immune response. The most prominent phenotype of the bile duct-ligated knockout animals was the higher bacterial burden found in their blood and livers, which was associated with severe differences in mortality rates. Thus, we tested the hypothesis, if the cross talk between hepatocellular c-Met and gp130-dependent signalling is crucial in regulating the hepatic antibacterial defence in vivo.
The relevance of bacterial translocation via the gut in general and the potential role of bacterial toxins during cholestasis were highlighted previously. Seki et al demonstrated that intestinal microbes are involved in triggering progression of liver fibrosis in mice during cholestatic liver injury through a TLR4-dependent mechanism. Here, LPS binds LBP and its co-receptor CD14, which form a complex with TLR4 and subsequently activate downstream hepatic anti-microbial pathways. Our present data demonstrate that c-Met and gp130-dependent signalling differentially regulates the expression of receptors leading to the activation of TLR4-dependent pathways.
Gp130 deficiency resulted in reduced expression of LBP while the LBP co-receptor CD14 was upregulated. This finding had no impact on the invasion of bacteria into the liver, however, (Figure 2b ) it was associated with more pronounced necrosis and early death. In contrast, CD14 was not increased in mice lacking c-Met expression either alone or in combination with gp130, a finding which is supported by our previously performed gene array 15 (Supplementary Table 1) .
Dysregulation of the LBP/CD14 complex is thought to be relevant during progression of chronic cholestatic liver injury as gut sterilisation slows the development of liver fibrosis. 1 In addition, CD14 polymorphisms are associated with increased susceptibility during the progression of cholestatic liver disease. 23 As LBP is involved in controlling the innate immune response and also hepatic tissue reconstitution 24 the lack of its regulation in gp130-deleted mice very likely contributes to the severe phenotype found after BDL.
MyD88, a downstream molecule, involved in TLR4 signalling is essential to mediate survival during bacterial infections. 1, 25 Interestingly, the expression of MyD88 was not increased in gp130
Dhepa and c-Met/gp130 Dhepa mice, as one would have expected in relation to the bacterial load found in those mice. However, a gp130-dependent gene expression of MyD88 in hepatocytes was previously shown. 26 In contrast, MyD88 expression was induced in c-Met Dhepa mice, which might explain why these mice did not suffer from early mortality despite their significantly higher hepatic bacterial load compared with wt animals. MyD88 is also involved in TLR2, 4 and IL-1 receptor signalling and thus this observation suggest that activation of these pathways is impaired in those mice (Figures 4a and d) . TRAF6 is located further downstream of MyD88 and thus is one of the gatekeepers for MyD88-induced signalling. TRAF6 is only upregulated in control mice after BDL, whereas it remained unchanged in mice lacking either c-Met or gp130. As TRAF6 is part of the MyD88-IRAK complex it is involved in inducing NF-kB via TAK1 and the hepatic immune response. 27 The relevance of this observation is strengthened by the finding of reduced IRAK4 mRNA and protein expression in these mice, which is an important regulatory kinase of this pathway. Furthermore, we would suggest a more critical role of STAT proteins in the regulation of IRAK4 gene expression, because STAT3 activation is significantly reduced by either c-Met or gp130-pathway deficiency. In parallel to IRAK4 also TIRAP, another TLR4 adaptor molecule involved in LPS-related TLRs signalling 4 was only induced in control mice further supporting the finding that c-Met or gp130 expression is essential in directly regulating the antibacterial response in hepatocytes.
The p38 MAPK pathway can be activated by different upstream kinases including TRAF6. However, in c-Met Dhepa , gp130
Dhepa and c-Met/gp130 Dhepa mice a stronger inflammatory response, eg, higher TNF, IL-1a and IL-6 was found. This observation explains why despite lower TRAF6 expression the knockout animals showed stronger p38 induction as these mediators can activate p38 independent of TRAF6. The change in the pro-inflammatory response is likely triggered by the higher bacterial load. The need for an ongoing inflammatory reaction in the knockout strains blocks the activation of an anti-inflammatory cascade and therefore low IL-4 expression was evident in these livers. The stronger degree of liver injury in the receptor-deleted mice can also be related to the reduced activation of JNK and p42/44 MAPK, as both were found to be less phosphorylated (Figures 6f and g ). Previous analysis of JNK described especially for JNK1 a protective role 28 in hepatocytes. Thus, the missing activation of both phosphokinases might explain the increased tissue damage. Here, further research is necessary to define the role of JNK in individual cell types, as it is proven to be an important regulator of liver injury.
These mechanisms trigger stronger infiltration of immune cells into the liver. They are in term able to produce so-called AMPs, which contribute to the antibacterial defense. The main sources of AMPs-such as the CRAMP-are neutrophils. Neutrophils are also the most important cellular effectors recruited to the site of inflammation and injury to resolve organ damage. 29 In our animals, we found a direct correlation between the number of infiltrating neutrophils and CRAMP expression. CRAMP was also induced by LPS in primary hepatocytes (Supplementary Figure 2a) , although the overall expression level here is lower than that in immune cells. At present, hepatocytes have not been described as producers of AMPs. Thus, their contribution to the innate immune and specifically to the antibacterial response might have been underestimated so far.
The consecutive analysis of the innate immune response evidenced a changed expression of hepatic intracellular pathogen recognition receptors. Expression of NOD-1-an essential factor mediating the recognition of Gram-negative bacteria and trigger for the innate immune response in epithelial and immune cells 30 -was somewhat unexpectedly reduced in gp130 Dhepa mice. Nlrp3 was concordantly mostly induced in c-Met Dhepa mice, in contrast to gp130-deleted mice. The gp130 restricted expression of those members of the inflammasome complex 31 thus correlated with survival of bile duct-ligated mice. But, further research is necessary to better differentiate between individual cell types, which contribute to the expression of the components of the inflammasome complex. Here, gp130-deficient mice might represent a valuable tool for future analysis. This imbalance in the inflammasome complex can also explain the higher number of immune cells recruited to the livers of c-Met Dhepa , gp130 Dhepa and c-Met/gp130 Dhepa mice (see Figures 1b and d) .
Our finding of increased mortality due to the bacterial load was further supported by investigating a second unspecific antibacterial response system of the liver-the APR. In agreement with our earlier results, regulation of APR was completely blocked in gp130 Dhepa mice as evidenced by blunted STAT3 phosphorylation and expression of STAT3-dependent genes, SAA and Hepcidine. However, also in c-Met Dhepa mice the induction of the APR was significantly reduced. These findings are supported by our earlier gene array analysis and thus contribute to the higher bacterial burden found in these animals after BDL.
In summary, our observation of increased tissue damage after BDL in c-Met
Dhepa and higher early lethality in gp130
Dhepa and c-Met/gp130 Dhepa mice can be attributed to several possible mechanisms. First, the impaired antibacterial response results in increased bacterial burden. Especially in gp130
Dhepa and c-Met/gp130 Dhepa a correct regulation of members of the innate immune response is impaired, which leads to insufficient TLR4-and IL-1-induced signalling and earlier death. Second, higher bacterial load triggers a stronger pro-inflammatory response, eg, TNF-a, which induces proinflammatory and pro-apoptotic/necroptotic pathways, including bile duct remodelling. In addition, the reduced APR in c-Met and especially gp130-deficient mice contributes to a significantly higher degree of liver damage.
